GISSOC II: Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total Coronary Occlusions
A Randomized Comparison of Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total Coronary Occlusions: The Gruppo Italiano di Studio Sullo Stent Nelle Occlusioni Coronariche. The GISSOC II Study.
Sponsor: Cordis Italy a division of Johnson & Johnson Medical SpA
A PHASE4 clinical study on Coronary Artery Disease, this trial is ongoing. The trial is conducted by Cordis Italy a division of Johnson & Johnson Medical SpA and has accumulated 6 data snapshots since 2005. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
First recorded
May 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cordis Italy a division of Johnson & Johnson Medical SpA
- Società Italiana di Cardiologia Invasiva
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Arezzo, Italy , Bergamo, Italy , Bologna, Italy , Catania, Italy , Como, Italy , Genoa, Italy , Genova, Italy , Legnano, Italy , Mestre, Italy , Padua, Italy and 4 more locations